The FEI has announced two new adverse findings in horses involving prohibited substances.
Samples taken at the CSIO2* in Tehran, Iran, late in September from the showjumping horse Sir de Diamant, ridden by Mohammad Davoud Shekofti, of Iran, were positive for the banned substance stanozolol and its metabolite, 16 beta hydroxy-stanozol. It is an anabolic steroid that promotes muscle mass.
The horse’s sample also tested positive for the controlled medication dexamethasone, a corticosteroid used to treat inflammatory and auto-immune conditions, and the non-steroidal anti-inflammatory drug flunixin.
Samples taken at the Young Horse Endurance Championships in Valeggio sul Minico, Italy, on September 26 from the horse Barbaforte Bosana, ridden by Camilla Malta, of Italy, have tested positive for the banned substance ergonovine, a vasoconstrictor.
Both athletes have been provisionally suspended from November 16 – the date of notification. The horses have been provisionally suspended for two months.
Read more at Horsetalk.co.nz
The FEI Tribunal has issued its Final Decisions in three equine anti-doping cases involving Prohibited Substances
Inside.FEI.org 21 October 2020 The first case involves the horse Caipirina (FEI ID 105RC16/COL), ridden by Major Juan Pablo Garcia Sa...
Horsetalk.co.nz - Full Article January 2, 2020 Horsetalk.co.nz The Dutch equestrian body is considering whether it can deny riding perm...
Horseandhound.co.uk - Full Article Becky Murray 2 January, 2020 14:30 Calls have been made for the “fullest possible” investigation aft...
November 4 2013 "Our current FEI [endurance] rules are founded on ethical compromise, bias, and the warped sense of reality of powerf...